Your browser doesn't support javascript.
loading
Adventures with the ß2-adrenoceptor Receptor: A Career Long Interest in Agonising One of the Most Widely Studied GPCRs.
Fairhurst, Robin A.
Afiliación
  • Fairhurst RA; Novartis Oncology Disease, Basel, CH-4056, Switzerland. robin.fairhurst@novartis.com.
Chimia (Aarau) ; 78(7-8): 483-498, 2024 Aug 21.
Article en En | MEDLINE | ID: mdl-39221844
ABSTRACT
Drug discovery is a multi-disciplinary effort in which groups with expertise in a range of areas combine in a unified way to achieve a common goal to deliver a clinical candidate to evaluate a hypothesis for improving human health. As a medicinal chemist this environment has provided multiple opportunities to be involved in cross-discipline interactions that have been both rewarding and led to outcomes that would not have been possible without an intimate interdisciplinary curiosity. Within this article I aim to share some of my experiences with the ß2-adrenoceptor that have fostered such synergistic relationships with several disciplines, but in particular with in vitro pharmacologists looking at different ways to stimulate this G protein-coupled receptor (GPCR). This interest now spans over a quarter of a century and has been intertwined with the delivery of three clinical candidates.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Adrenérgicos beta 2 Límite: Humans Idioma: En Revista: Chimia (Aarau) / Chimia (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Adrenérgicos beta 2 Límite: Humans Idioma: En Revista: Chimia (Aarau) / Chimia (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Suiza